Sublocade Alternatives Compared
| Sublocade (buprenorphine) | Buprenorphine | Brixadi (buprenorphine) |
|
|---|
| Sublocade (buprenorphine) | Buprenorphine | Brixadi (buprenorphine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Sublocade is a once-monthly injection that may be used to treat adults with opioid use disorder and is administered subcutaneously (under the skin) into the stomach (abdomen), thigh, buttock, or... View more |
Prescription only
Buprenorphine is a potent analgesic that should be only used to treat moderate to severe pain or for the treatment of opioid addiction under strict conditions. Different formulations of the drug... View more |
Prescription only
Prescribed for Opiate Dependence - Maintenance, Opioid Use Disorder. Brixadi may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||
| More about Sublocade (buprenorphine) | More about Buprenorphine | More about Brixadi (buprenorphine) | ||||||||
| Ratings & Reviews | ||||||||||
|
Sublocade has an average rating of 7.9 out of 10 from a total of 307 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 14% reported a negative effect. |
Buprenorphine has an average rating of 6.7 out of 10 from a total of 1154 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 25% reported a negative effect. |
Brixadi has an average rating of 6.0 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Sublocade side effects |
View all Buprenorphine side effects |
View all Brixadi side effects |
||||||||
| Drug Class | ||||||||||
|
None |
None |
|||||||||
| Generic Availability | ||||||||||
|
Lower cost generic |
||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Buprenorphine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
| Other buprenorphine brands include: Belbuca, Brixadi, Buprenex, Butrans | Belbuca, Brixadi, Buprenex, Butrans, Sublocade | Other buprenorphine brands include: Belbuca, Buprenex, Butrans, Sublocade | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
48 hours |
48 hours |
48 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 726 drugs are known to interact with Sublocade:
|
A total of 726 drugs are known to interact with Buprenorphine:
|
A total of 726 drugs are known to interact with Brixadi:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
|
|
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
November 30, 2017 |
December 29, 1981 |
May 23, 2023 |
||||||||
| WADA Class View classifications | ||||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.